Market Trends of Europe Ablation Technologies Industry
This section covers the major market trends shaping the Europe Ablation Technologies Market according to our research experts:
Radiofrequency Ablation is Expected to Register a Significant Growth Rate over the Forecast Period
Radiofrequency ablation is a medical procedure in which part of the electrical conduction system of the heart, tumor, or other dysfunctional tissue is ablated using the heat generated from medium-frequency alternating current. The factors propelling the studied market growth are the increasing prevalence of minimally invasive procedures, the growing burden of chronic diseases, and the senior population. For instance, according to the British Heart Foundation England Factsheet, published in January 2022, about 6.4 million people are living with cardiovascular diseases in England. Also, as per the British Heart Foundation 2020 fact sheet, around 7.4 million people are living with heart and circulatory diseases in the United Kingdom. Thus, the rise in chronic diseases will significantly drive the growth of the studied market.
Moreover, market players in Europe focus on growth strategies such as new product launches, partnerships, mergers, and acquisitions, which are driving the growth of the segment over the forecast period. For instance, in October 2022, Biosense Webster, Inc., part of Johnson & Johnson MedTech, launched HELIOSTAR Balloon Ablation Catheter, the first radiofrequency balloon ablation catheter in Europe. The HELIOSTAR Balloon Ablation Catheter is indicated for use in the catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria and, when used with a compatible multi-channel RF generator, for cardiac ablation. Such initiatives undertaken are expected to contribute to the growth of the segment.
Thus, the segment is expected to witness significant growth over the forecast period due to the abovementioned factors.
Germany is Expected to Show a Significant Share of the Market Over the Forecast Period
Germany is likely to grow in the ablation technologies market owing to factors such as the increasing burden of cardiovascular diseases. As per the German Heart Surgery Report 2021 statistics, in 2021, there were about 161,261 cardiac procedures performed in Germany out of 36,714 heart valve procedures, and 19,490 were pacemaker and ICD-related systems. Such a high number of cardiac procedures increases the demand for ablation devices in Germany.
The technological advancements in ablation technologies, expansion, launches, and innovations by key market players in Germany are likely to boost segmental growth over the forecast period. For instance, in December 2022, TechsoMed Ltd. opened German Subsidiary as a strategic collaboration with the Research Institute Fraunhofer MEVIS, to accelerate end-to-end solutions for image-guided tumor ablation therapy. Such development is expected to drive the growth of the market over the forecast period.
Thus, given the factors above, the studied market is expected to grow significantly in Germany over the forecast period.
